2019 CC Biotech. Ltd.

CC Bio Secure Position on P4 Precision Medicine Accelerator - 25/6/19

 

Precision medicine is the future of healthcare. And, with precision at the core of what we do, CC Bio are delighted to be named as one of a handful of ventures to secure a position on the P4 precision medicine accelerator

Led by Professor Phil Beales Chair of the UCL Institute of Precision Medicine and Capital Enterprise, P4 is a 6 month scale up programme providing mentorship, regulatory pathway support, specialised investor introductions, access to key decision makers, product testbed and trial opportunities, and 6 months access to a co-working in central London.


 


The Accelerator
'seeks the worlds leading Precision Medicine startups to support through development, regulation, investment, adoption and scale to UK and international markets to innovate and advance the healthcare landscape.'

 

And,
 

'curates an ecosystem of physical space and specialist to support precision medicine innovations to develop research into world leading technology, support to gain regulatory approval and adoption not only to the UK healthcare system but scale internationally.'